Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genome-wide Mendelian Randomization Identifies Potential Drug Targets for Dorsopathies

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 13:42
  • Read more about Genome-wide Mendelian Randomization Identifies Potential Drug Targets for Dorsopathies

The genetic architecture of and evolutionary constraints on the human pelvic form

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 13:37
  • Read more about The genetic architecture of and evolutionary constraints on the human pelvic form

Elucidating the association of obstructive sleep apnea with brain structure and cognitive performance

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:38
  • Read more about Elucidating the association of obstructive sleep apnea with brain structure and cognitive performance

The causal role of multiple psycho-emotional disorders in gastroesophageal reflux disease: A two-sample Mendelian randomized study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:36
  • Read more about The causal role of multiple psycho-emotional disorders in gastroesophageal reflux disease: A two-sample Mendelian randomized study

Causal association between circulating inflammatory cytokines and intracranial aneurysm and subarachnoid hemorrhage

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:34
  • Read more about Causal association between circulating inflammatory cytokines and intracranial aneurysm and subarachnoid hemorrhage

A Mendelian randomization study of the effect of selenium on autoimmune thyroid disease

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:30
  • Read more about A Mendelian randomization study of the effect of selenium on autoimmune thyroid disease

Association between gut microbiota and spinal stenosis: a two-sample mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:28
  • Read more about Association between gut microbiota and spinal stenosis: a two-sample mendelian randomization study

Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:19
  • Read more about Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials

A causal analysis of the relationship between exposure to sunlight and colorectal cancer risk: A Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 12:18
  • Read more about A causal analysis of the relationship between exposure to sunlight and colorectal cancer risk: A Mendelian randomization study

Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 11:07
  • Read more about Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 277
  • Page 278
  • Page 279
  • Page 280
  • Current page 281
  • Page 282
  • Page 283
  • Page 284
  • Page 285
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement